NeuroSolutions Ltd. offers a cost-effective hERG screening service designed to help global pharma and biotech companies make timely and reliable go/no go decisions on the further discovery and development of new drug candidates.

We offer automated patch clamp assays using Sophion's QPatch system, as well as manual patch clamp assays to the industry 'Gold Standard' for hERG inhibition data.

The success of the NeuroSolutions' service is based on our proprietary assays and protocols using "best in class" equipment, as well as our skills and experience in the interpretation of hERG test results.